Valuation : OneSource Specialty Pharma Limited

Market Cap 178B 1.88B 1.62B 1.52B 1.39B 2.6B 2.61B 18.05B 6.98B 91.14B 7.07B 6.91B 290B P/E 2027 *
38.3x
P/E 2028 * 18.5x
Enterprise Value 187B 1.98B 1.7B 1.6B 1.46B 2.73B 2.74B 18.95B 7.32B 95.67B 7.42B 7.26B 305B EV / Sales 2027 *
8.57x
EV / Sales 2028 * 5.27x
Free-Float
64.51%
Yield 2027 *
-
Yield 2028 * -
1 day+1.75%
1 week+3.38%
Current month+3.98%
1 month+0.26%
3 months-9.11%
6 months+4.26%
Current year-12.76%
1 week 1,509
Extreme 1509
1,645.7
1 month 1,478
Extreme 1478
1,647
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-29
Director of Finance/CFO - 2024-07-03
Compliance Officer - 2023-03-13
Director TitleAgeSince
Director/Board Member 65 2021-04-06
Director/Board Member 54 2024-02-29
Director/Board Member 66 2025-02-26
Change 5-day change 1-year change 3-year change Capi.($)
+1.75%+3.38%-13.93% - 1.88B
-0.57%-3.12%-1.82%+15.71% 48.41B
-0.40%+2.16%+418.57%+554.47% 45.01B
-1.42%+2.52%+42.67%+22.27% 44.07B
-1.22%-0.37%+4.82%+84.42% 40.73B
-0.96%-1.38%+15.75%+45.91% 33.21B
-0.21%+2.86% - - 17.77B
-0.35%-0.45%+21.42%+117.63% 16.5B
-0.56%-0.50%+11.39%+31.41% 14.45B
-1.65%+0.09%+75.93%+41.15% 13.77B
Average -0.55%+0.48%+63.86%+114.12% 27.58B
Weighted average by Cap. -0.81%-0.01%+88.71%+135.17%

Financials

2027 *2028 *
Net sales 21.8B 230M 198M 186M 170M 318M 319M 2.21B 854M 11.16B 866M 847M 35.56B 34.02B 360M 309M 291M 266M 497M 498M 3.45B 1.33B 17.42B 1.35B 1.32B 55.49B
Net income 4.46B 47.15M 40.55M 38.14M 34.81M 65.11M 65.32M 452M 175M 2.28B 177M 173M 7.27B 8.97B 94.83M 81.55M 76.7M 70.02M 131M 131M 909M 352M 4.59B 356M 348M 14.63B
Net Debt 8.86B 93.64M 80.53M 75.74M 69.14M 129M 130M 898M 347M 4.54B 352M 344M 14.45B 1.16B 12.31M 10.58M 9.96M 9.09M 17M 17.05M 118M 45.63M 596M 46.22M 45.21M 1.9B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,674
Date Price Change Volume
26-09-08 1,579.50 +1.75% 707,456
26-09-07 ₹1,552.30 +0.94% 140,096
26-09-04 ₹1,537.80 -2.41% 112,994
26-09-03 ₹1,575.70 +2.03% 118,656
26-09-02 ₹1,544.40 +1.08% 136,288
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,552.30INR
Average target price
2,056.00INR
Spread / Average Target
+32.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!